FDA approves extra bivalent boosters for high-risk groups
The U.S. Food and Drug Administration amended the terms of its emergency use authorizations for the Pfizer and Moderna bivalent vaccines on Tuesday, allowing people ages 65 and older and certain people with weakened immunity to get additional doses before this fall's vaccination campaigns.
The U.S. Food and Drug Administration updated its emergency use authorizations for Pfizer and Moderna bivalent vaccines. This change permits individuals aged 65 and above, as well as those with compromised immune systems, to receive additional doses. The adjustment is intended to enhance protection ahead of the upcoming vaccination season. The decision reflects ongoing efforts to address public health needs. It aims to provide better defense against evolving virus strains. The update highlights the FDA's role in adapting to new medical evidence. It ensures that vulnerable populations have access to necessary healthcare measures.
It helps protect those most at risk from severe illness during the upcoming season.
📌 Kaynak
Bu haber XML kaynağından derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →